Weitzmann Institute researchers reach milestone in pancreatic transplants for diabetic animals
Posted on August 8, 2007 • By Deena Levenstein
Category: Science |
The TissEra sponsored research team at the Weitzmann Institute of Science is finding that transplanted pancreatic tissue in insulin-dependent (type I) diabetic large animals substantially reduces the amount of external insulin needed in order to regulate blood sugar levels.
In the experiments, the animals are first given an agent that induces destruction of their pancreatic cells. Following this, insulin is administered for a few weeks in order to regulate their blood sugar levels. Then pig embryonic pancreatic tissue is transplanted into the animals.
The researchers have noted a 90% reduction in the amount of exogenous insulin needed by the fourth month after the transplant relative to immediately before the procedure.
TissEra is an Israeli company dedicated to the advancement of a new era in tissue transplantation with precursor transplant technology.
If you liked this post, be sure to subscribe to our RSS feed.
Leave a Comment
If you would like to make a comment, please fill out the form below.
About israelplug
Upcoming Events
You may have missed
Search
Subscribe to israelplug
Categories
Sponsors